Day in and day out, companies continue to clamor for the NVIDIA GPUs that are powering the AI revolution. Here are some of the big collaborations and partnerships that the company has announced (so ...

Eli Lilly upgraded on coverage expansion for obesity drugs Leerink Partners upgraded Eli Lilly (LLY) to Outperform from Market Perform, arguing that its recent pricing deal with the Trump ...

The latest investor updates on stocks that are trending on Wednesday.

If the headline yield today is not something you’re concerned with, and you pay more attention to how fast a yield can grow, ...

Pfizer (NYSE:PFE) stock rose 0.6% after the U.S. pharma giant clinched a $10 billion deal for obesity drug developer Metsera, ...

Here are some of the stocks making notable moves in Monday's premarket action: TreeHouse Foods shares are surging 19% after the food and beverage company agreed to be taken private by Industrial F&B ...

Coming back to SoftBank, does the $5.83 billion Nvidia exit symbolise a red flag for AI? Hardly. It’s part of a broader ...

Metsera falls sharply after Pfizer agrees to buy the weight-loss drug start-up in a deal that could be worth more than $10 ...

US stocks rose Monday as Nvidia led tech gains, Apple delayed the iPhone Air, Pfizer acquired Metsera, and Trump unveiled a ...

It is a broadly accepted truth that merger activity is the product of “animal spirits”. Over the past couple of years, though ...

Nvidia stock is set to be driven by investment in artificial-intelligence infrastructure from Microsoft and Meta but it also needs to fend off rivals. Same-store sales have been slumping, and that’s a ...